Sona Nanotech Inc. (SONA.CN)
Sona Nanotech Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Halifax, NS, CA. The stock last traded at $0.35, up 2.94% on the session, giving a market capitalisation of $40.0M. Its beta of 0.98 implies it has historically moved less than the broad market.
Based in Halifax, Canada, Sona Nanotech Inc. is a life sciences company focused on nanotechnology. It develops and commercializes gold nanorod solutions primarily for diagnostic applications. Their product portfolio includes the Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic test designed to detect the SARS-CoV-2 spike protein antigen in saliva from individuals suspected of having the virus. The company also offers Gemini and Omni gold nanorods, with the latter specifically engineered for medical uses, in addition to providing contract services. These versatile products are utilized in a wide array of applications, such as targeted drug delivery, environmental and food safety monitoring, cellular visualization, cancer therapy, liposuction treatments, and diagnostic tools for medical, consumer, military, and veterinary sectors.
Sona Nanotech Inc. is most often compared with the following Healthcare names: